Efficacy and safety of cryotherapy in comparison with Chinese herbal medicine in the treatment of chronic cervicitis and cervical erosion

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT201512107265N4

Enrollment

Registered

2016-06-14

Start date

2015-12-19

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic cervicitis. Inflammatory disease of cervix uteri

Interventions

Intervention 1: Intervention group: Cervicitis Treatment Tray which is a patent made by Beijing Jinyongyuan Medical applianceco. It mainly contains Cortex Phellodendri. The herbal formulation is plac

Treatment - Drugs

Treatment - Other

Intervention group: Cervicitis Treatment Tray which is a patent made by Beijing Jinyongyuan Medical applianceco. It mainly contains Cortex Phellodendri. The herbal formulation is placed on a plastic

Control group: cryotherapy

Eligibility

Sex/Gender

Female

Age

12 Years to 60 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Developing chronic cervicitis or cervical erosion; Papanicolaou smear class 1 or 2; Normal colposcopy. Exclusion criteria: Papanicolaou smear indicating papilloma or CIN; Sensitivity to plastic materials; Cervical prolapse greater than grade 1

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
The degree of cervicitis. Timepoint: Before intervention, 48 hours after the intervention, one week after the intervention, 3 days after the end of the next menstruation and at weeks 6 and 12. Method of measurement: clinical examination of cervix (observation) and recording in the study check list.	—

Secondary

Measure	Time frame
Complications. Timepoint: 48 hours after the intervention, one week after the intervention, 3 days after the end of the next menstruation and at weeks 6 and 12. Method of measurement: questionnaire.;Time to treatment response. Timepoint: Before intervention, 48 hours after the intervention, one week after the intervention, 3 days after the end of the next menstruation and at weeks 6 and 12. Method of measurement: clinical examination of cervix (observation) and recording in the study check list.	—

Measure

Time frame

Complications. Timepoint: 48 hours after the intervention, one week after the intervention, 3 days after the end of the next menstruation and at weeks 6 and 12. Method of measurement: questionnaire.;Time to treatment response. Timepoint: Before intervention, 48 hours after the intervention, one week after the intervention, 3 days after the end of the next menstruation and at weeks 6 and 12. Method of measurement: clinical examination of cervix (observation) and recording in the study check list.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Hoda Azizi

Department of Chinese and Complementary Medicine

azizih@mums.ac.ir+98 51 3855 2188

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026